Tag: Erik Kinnman

NeuroVive completes enrollment in KL1333 clinical trial for mitochondrial disease

pharmanewsdaily- December 23, 2019

KL1333 clinical trial : Swedish biotech company NeuroVive Pharmaceutical has wrapped up recruitment of healthy volunteers in the second part of its ongoing phase Ia/b ... Read More